Review





Similar Products

nu7441  (Tocris)
95
Tocris nu7441
Nu7441, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nu+7441/NU+7441/pm41874365-352-9-12
Average 95 stars, based on 1 article reviews
nu7441 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
sml1321 dna pk inhibitor dna pki nu 7441 selleckchem  (Selleck Chemicals)
96
Selleck Chemicals sml1321 dna pk inhibitor dna pki nu 7441 selleckchem
Sml1321 Dna Pk Inhibitor Dna Pki Nu 7441 Selleckchem, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nu+7441/NU7441/pm41270757-246-145-150
Average 96 stars, based on 1 article reviews
sml1321 dna pk inhibitor dna pki nu 7441 selleckchem - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
nhej inhibitors nu7441  (Tocris)
95
Tocris nhej inhibitors nu7441
Nhej Inhibitors Nu7441, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nu+7441/NU+7441/bio_rxiv__2025__11__12__688041-249-4-9
Average 95 stars, based on 1 article reviews
nhej inhibitors nu7441 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
h 1 benzopyran 4 one  (Tocris)
95
Tocris h 1 benzopyran 4 one
H 1 Benzopyran 4 One, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nu+7441/NU+7441/pm41115973-61-10-37
Average 95 stars, based on 1 article reviews
h 1 benzopyran 4 one - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
nu 7441  (Tocris)
95
Tocris nu 7441
Synthetic lethal combinations enhance apoptosis, induce cell cycle defect and activate DDR. (A, B) U2932 and DB cell lines were treated as indicated with IC20 of each drug (U2932 cell line: Cyclophosphamide 1 µM, PF477736 0.31, AZD‐6738 1.01 µM, Doxorubicin 30 <t>nM,</t> <t>NU7441</t> 3.1 µM; DB cell line: Cyclophosphamide: 0.8 μM, PF477736 0.39, AZD‐6738 3.13 µM, Doxorubicin 30 nM, NU7441 3.1 µM). Apoptosis was studied by AnnexinV‐PE staining and cell cycle was studied using BrdU incorporation and DAPI after 72H of treatment. Data are the mean ± SD of three independent experiments. Statistical significance was tested using t ‐test for pairs. * p < 0.05, ** p < 0.01, *** p < 0.001, NS: non‐significant.
Nu 7441, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nu+7441/NU+7441/pmc12374179-61-13-11
Average 95 stars, based on 1 article reviews
nu 7441 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
nu 7441  (Selleck Chemicals)
96
Selleck Chemicals nu 7441
Synthetic lethal combinations enhance apoptosis, induce cell cycle defect and activate DDR. (A, B) U2932 and DB cell lines were treated as indicated with IC20 of each drug (U2932 cell line: Cyclophosphamide 1 µM, PF477736 0.31, AZD‐6738 1.01 µM, Doxorubicin 30 <t>nM,</t> <t>NU7441</t> 3.1 µM; DB cell line: Cyclophosphamide: 0.8 μM, PF477736 0.39, AZD‐6738 3.13 µM, Doxorubicin 30 nM, NU7441 3.1 µM). Apoptosis was studied by AnnexinV‐PE staining and cell cycle was studied using BrdU incorporation and DAPI after 72H of treatment. Data are the mean ± SD of three independent experiments. Statistical significance was tested using t ‐test for pairs. * p < 0.05, ** p < 0.01, *** p < 0.001, NS: non‐significant.
Nu 7441, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nu+7441/NU7441/pmc12374179-61-13-17
Average 96 stars, based on 1 article reviews
nu 7441 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Synthetic lethal combinations enhance apoptosis, induce cell cycle defect and activate DDR. (A, B) U2932 and DB cell lines were treated as indicated with IC20 of each drug (U2932 cell line: Cyclophosphamide 1 µM, PF477736 0.31, AZD‐6738 1.01 µM, Doxorubicin 30 nM, NU7441 3.1 µM; DB cell line: Cyclophosphamide: 0.8 μM, PF477736 0.39, AZD‐6738 3.13 µM, Doxorubicin 30 nM, NU7441 3.1 µM). Apoptosis was studied by AnnexinV‐PE staining and cell cycle was studied using BrdU incorporation and DAPI after 72H of treatment. Data are the mean ± SD of three independent experiments. Statistical significance was tested using t ‐test for pairs. * p < 0.05, ** p < 0.01, *** p < 0.001, NS: non‐significant.

Journal: Hematological Oncology

Article Title: Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High‐Risk Diffuse Large B Cell Lymphoma

doi: 10.1002/hon.70131

Figure Lengend Snippet: Synthetic lethal combinations enhance apoptosis, induce cell cycle defect and activate DDR. (A, B) U2932 and DB cell lines were treated as indicated with IC20 of each drug (U2932 cell line: Cyclophosphamide 1 µM, PF477736 0.31, AZD‐6738 1.01 µM, Doxorubicin 30 nM, NU7441 3.1 µM; DB cell line: Cyclophosphamide: 0.8 μM, PF477736 0.39, AZD‐6738 3.13 µM, Doxorubicin 30 nM, NU7441 3.1 µM). Apoptosis was studied by AnnexinV‐PE staining and cell cycle was studied using BrdU incorporation and DAPI after 72H of treatment. Data are the mean ± SD of three independent experiments. Statistical significance was tested using t ‐test for pairs. * p < 0.05, ** p < 0.01, *** p < 0.001, NS: non‐significant.

Article Snippet: The compounds used in this study are PJ‐34 (PARP1/2 inhibitor; 3255 Tocris Bioscience), NU‐7441 (DNAPK inhibitor; S2638 Selleckchem), KU‐55933 (ATM inhibitor; S1092 Selleckchem), PF‐477736 (CHK1/2 inhibitor; S2904 Selleckchem), AZD‐6738 (ATR inhibitor; S7693 Selleckchem), MK‐8776 (CHK1 inhibitor; S2735 Selleckchem), AZD‐1775 (Wee1 inhibitor; S1525 Selleckchem), MP‐470 (Rad51 inhibitor; S1244 Selleckchem), Gemcitabine (nucleic acid synthesis inhibitor; S1714 Selleckchem), Doxorubicin and Etoposide (topoisomerase II inhibitors; D1515 Sigma Aldrich and S1225 Selleckchem, respectively), Mafosfamide (nitrogen mustard, active form of 4‐OH‐Cyclophosphamide; SC‐211761 Santa Cruz Biotechnology.

Techniques: Staining, BrdU Incorporation Assay

Synthetic lethal combinations enhance apoptosis, induce cell cycle defect and activate DDR. (A, B) U2932 and DB cell lines were treated as indicated with IC20 of each drug (U2932 cell line: Cyclophosphamide 1 µM, PF477736 0.31, AZD‐6738 1.01 µM, Doxorubicin 30 nM, NU7441 3.1 µM; DB cell line: Cyclophosphamide: 0.8 μM, PF477736 0.39, AZD‐6738 3.13 µM, Doxorubicin 30 nM, NU7441 3.1 µM). Apoptosis was studied by AnnexinV‐PE staining and cell cycle was studied using BrdU incorporation and DAPI after 72H of treatment. Data are the mean ± SD of three independent experiments. Statistical significance was tested using t ‐test for pairs. * p < 0.05, ** p < 0.01, *** p < 0.001, NS: non‐significant.

Journal: Hematological Oncology

Article Title: Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High‐Risk Diffuse Large B Cell Lymphoma

doi: 10.1002/hon.70131

Figure Lengend Snippet: Synthetic lethal combinations enhance apoptosis, induce cell cycle defect and activate DDR. (A, B) U2932 and DB cell lines were treated as indicated with IC20 of each drug (U2932 cell line: Cyclophosphamide 1 µM, PF477736 0.31, AZD‐6738 1.01 µM, Doxorubicin 30 nM, NU7441 3.1 µM; DB cell line: Cyclophosphamide: 0.8 μM, PF477736 0.39, AZD‐6738 3.13 µM, Doxorubicin 30 nM, NU7441 3.1 µM). Apoptosis was studied by AnnexinV‐PE staining and cell cycle was studied using BrdU incorporation and DAPI after 72H of treatment. Data are the mean ± SD of three independent experiments. Statistical significance was tested using t ‐test for pairs. * p < 0.05, ** p < 0.01, *** p < 0.001, NS: non‐significant.

Article Snippet: The compounds used in this study are PJ‐34 (PARP1/2 inhibitor; 3255 Tocris Bioscience), NU‐7441 (DNAPK inhibitor; S2638 Selleckchem), KU‐55933 (ATM inhibitor; S1092 Selleckchem), PF‐477736 (CHK1/2 inhibitor; S2904 Selleckchem), AZD‐6738 (ATR inhibitor; S7693 Selleckchem), MK‐8776 (CHK1 inhibitor; S2735 Selleckchem), AZD‐1775 (Wee1 inhibitor; S1525 Selleckchem), MP‐470 (Rad51 inhibitor; S1244 Selleckchem), Gemcitabine (nucleic acid synthesis inhibitor; S1714 Selleckchem), Doxorubicin and Etoposide (topoisomerase II inhibitors; D1515 Sigma Aldrich and S1225 Selleckchem, respectively), Mafosfamide (nitrogen mustard, active form of 4‐OH‐Cyclophosphamide; SC‐211761 Santa Cruz Biotechnology.

Techniques: Staining, BrdU Incorporation Assay